Research into biologic therapy for asthma and COPD has been both successful and frustrating. Find out what you know about the progress with these 8 questions.
Ongoing research into the use of biologic therapies for patients with asthma and chronic obstructive pulmonary disease (COPD) has produced mixed results to date with promise for the future.
Take this quick quiz to test your knowledge of key developments of the past few years.
Answer: D. Underlying pathways in the pathophysiology of asthma and COPD are targeted by biologic treatments.
Answer: A. Type 2 high. Biologic therapies were available by 2019 only for patients with these phenotypes.
Answer: D. All the above were issues highlighted by the European Academy of Allergy and Clinical Immunology for clarification.
Answer: A. 10% of patients in the CHRONICLE study of treatment of severe asthma switched among biologic agents as additional drugs were approved.
Answer: E. All the above. Authors from the Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Dundee, Scotland, United Kingdom identified all of these therapies for the asthma endotypes specified in their recent algorithm.
Answer: C. Hyaluron was found beneficial to treat severe acute exacerbations of COPD in a recent pilot study published in Respiratory Research.